L Decroix1,2, K De Pauw1, J Van Cutsem1, N Pattyn1,3, E Heyman2, R Meeusen4. 1. Human Physiology research group, Faculty of Physical Education and Physical Therapy, Vrije Universiteit Brussel, Pleinlaan 2, 1050, Brussel, Belgium. 2. Multi-disciplinary Research Unit of Sport, Heath and Society, URePSSS, University of Lille, Artois, Littoral Cote d'Opale, EA7369, 413 rue Eugène Avinée, 59120, Loos, France. 3. Vital Signs and Performance Research Unit, Royal Military Academy, Renaissancelaan 30, 1000, Brussels, Belgium. 4. Human Physiology research group, Faculty of Physical Education and Physical Therapy, Vrije Universiteit Brussel, Pleinlaan 2, 1050, Brussel, Belgium. romain.meeusen@vub.be.
Abstract
INTRODUCTION: Acute cocoa flavanols (CF) intake has been suggested to modulate cognitive function and neurovascular coupling (NVC). Whether increased NVC is solely driven by improved vascular responsiveness or also by neuronal activity remains unknown. This study investigated the effects of acute CF intake on cognitive performance, NVC, and neuronal activity in healthy subjects in normoxia and hypoxia (4000 m simulated altitude; 12.7% O2). METHODS:Twenty healthy subjects (age 23.2 ± 4.3 years) performed four trials. Participants performed a Stroop task and "cognition" battery 2 h after acute CF (530 mg CF, 100 mg epicatechin) or placebo intake, and 30 min after initial exposure to hypoxia or normoxia. Electroencephalogram and functional near-infrared spectroscopy were used to analyze hemodynamic changes and neuronal activity. RESULTS:CF enhanced NVC in the right prefrontal cortex during several tasks (risk decision making, visual tracking, complex scanning, spatial orientation), while neuronal activity was not affected. CF improved abstract thinking in normoxia, but not in hypoxia and did not improve other cognitive performances. Hypoxia decreased accuracy on the Stroop task, but performance on other cognitive tasks was preserved. NVC and neuronal activity during cognitive tasks were similar in hypoxia vs. normoxia, with the exception of increased β activity in the primary motor cortex during abstract thinking. CONCLUSIONS:Acute CF intake improved NVC, but did not affect neuronal activity and cognitive performance in both normoxia and hypoxia. Most cognitive functions, as well as NVC and neuronal activity, did not decline by acute exposure to moderate hypoxia in healthy subjects.
RCT Entities:
INTRODUCTION: Acute cocoa flavanols (CF) intake has been suggested to modulate cognitive function and neurovascular coupling (NVC). Whether increased NVC is solely driven by improved vascular responsiveness or also by neuronal activity remains unknown. This study investigated the effects of acute CF intake on cognitive performance, NVC, and neuronal activity in healthy subjects in normoxia and hypoxia (4000 m simulated altitude; 12.7% O2). METHODS: Twenty healthy subjects (age 23.2 ± 4.3 years) performed four trials. Participants performed a Stroop task and "cognition" battery 2 h after acute CF (530 mg CF, 100 mg epicatechin) or placebo intake, and 30 min after initial exposure to hypoxia or normoxia. Electroencephalogram and functional near-infrared spectroscopy were used to analyze hemodynamic changes and neuronal activity. RESULTS: CF enhanced NVC in the right prefrontal cortex during several tasks (risk decision making, visual tracking, complex scanning, spatial orientation), while neuronal activity was not affected. CF improved abstract thinking in normoxia, but not in hypoxia and did not improve other cognitive performances. Hypoxia decreased accuracy on the Stroop task, but performance on other cognitive tasks was preserved. NVC and neuronal activity during cognitive tasks were similar in hypoxia vs. normoxia, with the exception of increased β activity in the primary motor cortex during abstract thinking. CONCLUSIONS: Acute CF intake improved NVC, but did not affect neuronal activity and cognitive performance in both normoxia and hypoxia. Most cognitive functions, as well as NVC and neuronal activity, did not decline by acute exposure to moderate hypoxia in healthy subjects.
Authors: Andrew B Scholey; Stephen J French; Penelope J Morris; David O Kennedy; Anthea L Milne; Crystal F Haskell Journal: J Psychopharmacol Date: 2009-11-26 Impact factor: 4.153
Authors: Mathias Basner; Adam Savitt; Tyler M Moore; Allison M Port; Sarah McGuire; Adrian J Ecker; Jad Nasrini; Daniel J Mollicone; Christopher M Mott; Thom McCann; David F Dinges; Ruben C Gur Journal: Aerosp Med Hum Perform Date: 2015-11 Impact factor: 1.053
Authors: Derek D Schramm; Malina Karim; Heather R Schrader; Roberta R Holt; Nadine J Kirkpatrick; John A Polagruto; Jodi L Ensunsa; Harold H Schmitz; Carl L Keen Journal: Life Sci Date: 2003-07-04 Impact factor: 5.037
Authors: Oliver M Shannon; Lauren Duckworth; Matthew J Barlow; Kevin Deighton; Jamie Matu; Emily L Williams; David Woods; Long Xie; Blossom C M Stephan; Mario Siervo; John P O'Hara Journal: Front Physiol Date: 2017-06-09 Impact factor: 4.566
Authors: Gabriele Gratton; Samuel R Weaver; Claire V Burley; Kathy A Low; Edward L Maclin; Paul W Johns; Quang S Pham; Samuel J E Lucas; Monica Fabiani; Catarina Rendeiro Journal: Sci Rep Date: 2020-11-24 Impact factor: 4.379